This discrepancy may reflect the fact that the PKCα targeting of PHB2 for tumour suppression may be non-functional by PKA–BIG3–PP1Cα complex, thereby inducing an apparent ‘loss-of-function’ of the PHB2 protein. Here, PHB2 is linked to neoplasm.